What the Research Says
Zinc is involved in over 300 enzymatic reactions and is structurally integral to more than 1,000 transcription factors. Its immune role is among the most documented in micronutrient research. Zinc deficiency impairs the development of T lymphocytes, natural killer cells, and macrophages.
A 2000 Cochrane review of zinc supplementation in developing countries found remarkable reductions in pneumonia (41%) and diarrhea incidence (18%). For the common cold, a 2015 meta-analysis of 13 trials found zinc lozenges started within 24 hours of cold onset reduced duration by 33%.
Zinc's Role in Immune Function
- T cell development: Required for thymic hormone production and T lymphocyte maturation
- Natural killer cells: NK cell cytotoxicity depends on adequate zinc status
- Macrophage function: Phagocytosis and oxidative burst are zinc-dependent
- Antioxidant defense: Structural component of superoxide dismutase (SOD)
- Anti-inflammatory: Zinc finger proteins regulate NF-κB signaling
- Wound healing: Required for collagen synthesis and tissue repair
Zinc & the Common Cold
- Lozenges containing zinc acetate or gluconate (≥75mg/day) reduce cold duration by ~33% when started within 24 hours
- Ionic zinc may interfere directly with rhinovirus replication
- Nasal zinc (Zicam) was associated with anosmia and has been FDA-warned
- Lozenges or syrup — not tablets — are the studied delivery forms
Signs of Zinc Deficiency
- Frequent infections, slow wound healing
- Loss of taste or smell
- Hair thinning or loss
- Skin problems (acne, eczema)
- Night blindness
- Growth retardation (children)
- Hypogonadism in males
Forms of Zinc
- Zinc bisglycinate: Highest bioavailability, best tolerated — preferred
- Zinc gluconate: Well-studied for cold lozenges, good bioavailability
- Zinc acetate: Used in cold lozenge research, well-absorbed
- Zinc citrate: Good bioavailability, similar to gluconate
- Zinc oxide: Poor bioavailability — avoid
Dosage & Safety
- RDA: 8mg/day women, 11mg/day men
- Therapeutic dose: 25–40mg elemental zinc/day for immune support
- Cold lozenges: ≥75mg zinc/day every 2–3 hours while awake
- Tolerable upper limit: 40mg/day
- Copper balance: Long-term use >50mg/day can deplete copper — pair with 1–2mg copper
Frequently Asked Questions
Yes — multiple clinical trials show zinc lozenges or syrup (≥75mg/day, started within 24 hours of cold onset) reduce cold duration by approximately 33%. Zinc appears to inhibit rhinovirus replication. The effect is specific to zinc ionic forms in lozenges — tablets do not show the same benefit.
Zinc bisglycinate has the highest bioavailability and best GI tolerability, making it the preferred form for daily supplementation. Zinc gluconate and zinc acetate are well-studied for cold lozenges specifically. Zinc oxide has poor bioavailability and should be avoided.
Yes. The tolerable upper limit is 40mg/day for adults. Excessive zinc supplementation can deplete copper, causing copper deficiency anemia and neurological symptoms. High acute doses cause nausea and vomiting.
The elderly, vegetarians/vegans (phytates in plant foods inhibit absorption), alcoholics, those with GI conditions, pregnant and lactating women, and populations in low-income countries face highest deficiency risk.
In zinc-deficient men, supplementation restores testosterone to normal levels. However, evidence does not support testosterone enhancement above normal in zinc-sufficient individuals.
Research Summary
Zinc has strong, well-established evidence for immune function. Its role in cold duration reduction and immune cell development is among the most clinically actionable micronutrient findings.
- Evidence strength: Strong (4/5)
- Best form: Zinc bisglycinate (daily) / Zinc gluconate (cold lozenges)
- Daily dose: 25–40mg (maintain under 40mg UL)
- Cold lozenges: ≥75mg/day within 24h of onset
- Monitor copper with long-term use >50mg/day
References
All studies cited are peer-reviewed and publicly accessible. DOI and PubMed links open in a new tab.
- 1. Hemilä H (2017). Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. JRSM Open, 8(5). doi:10.1177/2054270417694291 PMID:28515951
- 2. Prasad AS (2008). Zinc in Human Health: Effect of Zinc on Immune Cells. Molecular Medicine, 14(5–6), 353–357. doi:10.2119/2008-00033.Prasad PMID:18385818
- 3. Shankar AH, Prasad AS (1998). Zinc and immune function: the biological basis of altered resistance to infection. American Journal of Clinical Nutrition, 68(2 Suppl), 447S–463S. doi:10.1093/ajcn/68.2.447S PMID:9701160
- 4. Saper RB, Rash R (2009). Zinc: An Essential Micronutrient. American Family Physician, 79(9), 768–772. PMID:20141096
- 5. Brown KH, Peerson JM, Rivera J, Allen LH (2002). Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: a meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition, 75(6), 1062–1071. doi:10.1093/ajcn/75.6.1062 PMID:12036814